184 related articles for article (PubMed ID: 24477596)
21. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
Chang RM; Xu JF; Fang F; Yang H; Yang LY
Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase 2 inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Zhang C; Wang H; Chen Z; Zhuang L; Xu L; Ning Z; Zhu Z; Wang P; Meng Z
Carcinogenesis; 2018 Apr; 39(4):562-570. PubMed ID: 29309535
[TBL] [Abstract][Full Text] [Related]
23. The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
Qin CD; Ma DN; Zhang SZ; Zhang N; Ren ZG; Zhu XD; Jia QA; Chai ZT; Wang CH; Sun HC; Tang ZY
Cell Death Dis; 2018 May; 9(5):486. PubMed ID: 29706627
[TBL] [Abstract][Full Text] [Related]
24. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
25. MST4 promotes hepatocellular carcinoma epithelial-mesenchymal transition and metastasis via activation of the p-ERK pathway.
Lin ZH; Wang L; Zhang JB; Liu Y; Li XQ; Guo L; Zhang B; Zhu WW; Ye QH
Int J Oncol; 2014 Aug; 45(2):629-40. PubMed ID: 24859810
[TBL] [Abstract][Full Text] [Related]
26. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
27. DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.
Xie B; Lin W; Ye J; Wang X; Zhang B; Xiong S; Li H; Tan G
J Exp Clin Cancer Res; 2015 Sep; 34(1):101. PubMed ID: 26362312
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
29. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
30. cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells.
Fu H; He Y; Qi L; Chen L; Luo Y; Chen L; Li Y; Zhang N; Guo H
Cancer Lett; 2017 Sep; 403():260-270. PubMed ID: 28649002
[TBL] [Abstract][Full Text] [Related]
31. [Inhibitory effect of full-length spleen tyrosine kinase on invasion and metastasis of human laryngeal squamous cells].
Li Z; Cai Z; Tao B; Jin Q
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 49(11):943-9. PubMed ID: 25598376
[TBL] [Abstract][Full Text] [Related]
32. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma.
Du ZM; Kou CW; Wang HY; Huang MY; Liao DZ; Hu CF; Chen J; Yan LX; Hu LF; Ernberg I; Zeng YX; Shao JY
Head Neck; 2012 Oct; 34(10):1456-64. PubMed ID: 22287277
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.
Wu X; Chen H; Gao Q; Bai J; Wang X; Zhou J; Qiu S; Xu Y; Shi Y; Wang X; Zhou J; Fan J
Mol Carcinog; 2014 Apr; 53(4):325-36. PubMed ID: 23169062
[TBL] [Abstract][Full Text] [Related]
35. CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.
Liu CH; Lan CT; Chou JF; Tseng TJ; Liao WC
Cancer Lett; 2017 Sep; 403():280-288. PubMed ID: 28652022
[TBL] [Abstract][Full Text] [Related]
36. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
[TBL] [Abstract][Full Text] [Related]
37. Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.
He L; Zhou X; Qu C; Hu L; Tang Y; Zhang Q; Liang M; Hong J
J Cell Mol Med; 2014 Jan; 18(1):49-58. PubMed ID: 24305552
[TBL] [Abstract][Full Text] [Related]
38. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
39. Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells.
Gao D; Wang L; Zhang H; Yan X; Yang J; Zhou R; Chang X; Sun Y; Tian S; Yao Z; Zhang K; Liu Z; Ma Z
FEBS J; 2018 Nov; 285(22):4229-4245. PubMed ID: 30251328
[TBL] [Abstract][Full Text] [Related]
40. ZnAs@SiO
Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]